Submitted by Anonymous (not verified) on 22 August 2024 - 13:40
Orphan designation: N-(1,3-Benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide Treatment of Platelet-activating anti-Platelet factor 4 (PF4) disorders, 24/05/2024 Positive
Source: